checkAd

     173  0 Kommentare Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - Seite 3

    For a more detailed discussion of related risk factors, please refer to our public filings available at www.sec.gov and www.sedar.com.

    For further information, please contact:

    Investors:
    Robert Andrade
    Chief Financial Officer
    Fennec Pharmaceuticals Inc.
    (919) 246-5299

    Lesen Sie auch

    Media:
    Elixir Health Public Relations
    Lindsay Rocco
    (862) 596-1304
    lrocco@elixirhealthpr.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - Seite 3 RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 (GLOBE NEWSWIRE) - Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in upcoming …